Vertex Ventures China
Vertex Ventures China is a venture capital firm that backs high-growth internet and technology startups across mainland China. Based in Beijing and Shanghai, it provides capital and growth-support services to portfolio companies and leverages the Vertex network of venture funds across the United States, Israel, Southeast Asia and India, supported by Vertex Holdings for local insight with a global perspective. The firm focuses on software, semiconductors, artificial intelligence, machine learning and edtech, aiming to help portfolio companies scale domestically and compete internationally.
Top Sectors
https://crunchbase.com/organization/***
https://linkedin.com/company/***
Past deals in Rotterdam
Harbour BioMed
Series B in 2018
Harbour BioMed is a biotechnology company focused on discovering and developing therapeutics for cancer and inflammatory diseases. Established in 2016 with operations in Shanghai, Cambridge, and Rotterdam, the company leverages its proprietary transgenic mouse platforms to generate fully human monoclonal antibodies (H2L2) and heavy chain only antibodies (HCAb), enabling the development of differentiated compounds such as bi-specific and multi-specific antibodies. Harbour BioMed collaborates strategically with various institutions and companies, including The Wistar Institute, WuXi Biologics, and Vir Biotechnology, to advance its pipeline of therapeutics targeting autoimmune diseases, dry eye disease, COVID-19, and other indications.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.